Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Oct 2026 for Contineum Therapeutics, Inc., €49k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Daniel Lorrain: trading record in brief
This profile gathers the share dealings of Daniel Lorrain in Contineum Therapeutics, Inc. We count 4 filings; the first trade dates from 30 June 2026 and the latest from 1 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 1 October 2026 with a transaction (€49k) in Contineum Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel Lorrain
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
4,170 shares@ US$13.42CommonSEC144:0001950047-26-009932
9,520 shares@ US$15.490.031% mcap100.0% of flowCommonSEC144:0001950047-26-007509
9,520 shares@ US$16.390.033% mcap26.6% of flowCommonSEC144:0001950047-26-006723
28,826 shares@ US$15.000.091% mcap73.4% of flowCommonSEC144:0001950047-26-006667
4 of 4 declarations
